SOLV · NYSE
Solventum (SOLV) Stock Price & Fundamentals
Solventum (SOLV) closed at $488.95 on Oct 9, 2026, down 0.30% from the previous close of $490.44.
Share price, past year
1Y +17.62%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $488.95 |
| Sep 30, 2026 | $494.12 |
| Aug 31, 2026 | $475.28 |
| Jul 31, 2026 | $451.06 |
| Jun 30, 2026 | $417.22 |
| May 29, 2026 | $433.83 |
| Apr 30, 2026 | $454.67 |
| Mar 31, 2026 | $409.32 |
| Feb 27, 2026 | $423.96 |
| Jan 30, 2026 | $417.83 |
| Dec 31, 2025 | $417.14 |
| Nov 28, 2025 | $432.34 |
| Oct 31, 2025 | $411.42 |
Key statistics
- Market cap
- $83.18B
- P/E (TTM)
- 58.7
- EPS (TTM)
- $8.33
- Revenue (TTM)
- $8.31B
- Net income (TTM)
- $1.43B
- Shares outstanding
- 170.1M
- Dividend yield
- —
- 52-week range
- $394.43 – $500.27
Solventum's market cap is $83.18B, based on a share price of $488.95 and 170.1M shares outstanding as of Jun 30, 2026.
Financials
Solventum reported revenue of $8.33B for fiscal 2025, up 0.86% from fiscal 2024.
Solventum earned net income of $1.56B in fiscal 2025, a net margin of 18.7%.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $8.33B | +0.9% | $1.56B | 18.7% | $8.88 | −$10.00M |
| FY2024ended Dec 31, 2024 | $8.25B | +0.7% | $479.00M | 5.8% | $2.76 | $805.00M |
| FY2023ended Dec 31, 2023 | $8.20B | +0.8% | $1.35B | 16.4% | $7.79 | $1.63B |
| FY2022ended Dec 31, 2022 | $8.13B | — | $1.34B | 16.5% | $7.78 | $1.43B |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $2.21B | $92.00M | $0.53 |
| Q1 FY2026ended Mar 31, 2026 | $2.01B | $13.00M | $0.07 |
| Q4 FY2025ended Dec 31, 2025 | $2.00B | $63.00M | — |
| Q3 FY2025ended Sep 30, 2025 | $2.10B | $1.27B | $7.22 |
| Q2 FY2025ended Jun 30, 2025 | $2.16B | $90.00M | $0.51 |
| Q1 FY2025ended Mar 31, 2025 | $2.07B | $137.00M | $0.78 |
| Q4 FY2024ended Dec 31, 2024 | $2.08B | $31.00M | — |
| Q3 FY2024ended Sep 30, 2024 | $2.08B | $122.00M | $0.70 |
Company profile
- Name
- Solventum Corp
- Ticker
- SOLV
- Exchange
- NYSE
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 1750 Yankee Doodle Road, Eagan, MN 55121
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001964738
Recent SEC filings
- Aug 5, 2026
- Aug 5, 2026
- Aug 5, 2026
- Jul 20, 2026
- Jun 5, 2026
- May 27, 2026
- May 20, 2026
- May 5, 2026
Frequently asked questions
What is Solventum's stock price?
Solventum (SOLV) closed at $488.95 on Oct 9, 2026, down 0.30% from the previous close of $490.44.
What is Solventum's market cap?
Solventum's market cap is $83.18B, based on a share price of $488.95 and 170.1M shares outstanding as of Jun 30, 2026.
How much revenue does Solventum make?
Solventum reported revenue of $8.33B for fiscal 2025, up 0.86% from fiscal 2024.
What is SOLV's P/E ratio?
Solventum's price-to-earnings ratio is 58.7, based on trailing twelve-month diluted EPS of $8.33.
Does Solventum pay a dividend?
Solventum's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Solventum Corp's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures